Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NanaBis
- Development stage
- Phase 3
- Lead developer
- Medlab Group
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Administration
- Buccal
01
Overview
MC-1019 (NanaBis) is a cannabis-based pharmaceutical formulation developed by Medlab Clinical. It contains a 1:1 ratio of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), with each milliliter containing approximately 9.62 mg of each cannabinoid. The drug utilizes Medlab's proprietary NanoCelle™ delivery platform, which creates sub-micron nanoparticles to enhance the absorption of the active ingredients through the oral mucosa (buccal delivery). MC-1019 targets the endocannabinoid system, specifically acting as an agonist at cannabinoid receptors CB1 and CB2 to modulate pain signaling. It is primarily being evaluated for the management of chronic pain, including cancer-related pain, and has been available to patients in Australia through the Special Access Scheme (SAS).
- Brand names
- NanaBisNanaDol
- Other names
- THC:CBD 1:1 buccal spraytetrahydrocannabinol + cannabidiol
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on NanaBis.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NanaBis.